Media

March 12, 2021

Allocator announces new partnership & collaboration with SharingAlpha

Our new partnership with SharingAlpha compliments our focus on building a collaborative network between capital allocators and hedge fund managers.

March 4, 2021

The transformative power of technology in alternative investments

This blog is the first in a series exploring topics from investments and strategy to decision support and data management. “57% of Allocators to Hedge Funds are planning to invest in data management in the next 12 months” 2021 Global Investment Survey on Emerging Technologies, Allocator. Global financial markets have arrived at a watershed moment, with…

February 26, 2021

CNBC Interview with the CEO and Founder at Allocator

Watch the exclusive CNBC interview about the 2020 Hedge Fund Performance and 2021 Top Performing Funds Since 2018, the Investors Choice Awards have gone digital. Competition is fierce, with more funds than ever before being considered in each peer group. More institutional investors are participating in the judging process than ever before, and all funds…

February 23, 2021

Free Nilsson Hedge database is now available on the Allocator platform

Allocator users can now access the free Nilsson Hedge CTA and Hedge Fund database in our cloud software, APIs and Excel Add In.

February 19, 2021

New partner: Nilsson Hedge | Get access to a free database

We are excited to announce a new partnership with Nilsson Hedge.Watch the video interviewwith the CEO and founder Linus Nilsson to understand the benefits of the new partnership, including:

December 16, 2020

The 2020 GIPS®: Driving business continuity and investor engagement

Q&A with two senior directors at CFA Institute on the revised 2020 GIPS standards

December 9, 2020

Assessing opportunities in Healthcare: Q&A with Dr Bianca Ogden

2020 has proven to be a volatile year for investment managers due to COVID-19. The emergence of new biotech and healthcare companies have tested sector specialist strategies even more than before. On the 21st of October 2020, we had the privilege of hosting Dr Bianca Ogden, Virologist Portfolio Manager at Platinum Asset Management to share their approach to…

December 7, 2020

Watch the Hedge Interview - Automating Data Management for Investors

In this episode of the Investor Views series, Ryan Kalish and Jennifer Bruno discuss how institutional investors are becoming more data-driven, how Allocator’s product developments are a direct result of client requests for data technology solutions and Allocator’s new alliance with Morningstar. We also talked about the importance of communication and how…

December 7, 2020

How to find quality companies to invest in Healthcare and Biotech?

2020 has proven to be a volatile year for investment managers due to COVID-19. The emergence of new biotech and healthcare companies have tested their strategies even more than before. Lockdowns have adversely impacted global markets, and as a result, Allocators have had to weather the storm of turbulent times. Managers have adapted their strategies in…

December 7, 2020

Three potential pitfalls of not adopting the 2020 GIPS® standards

In our last blog, Olivier Lebleu, Senior Director of Institutional Relations, EMEA and Iain McAra, Director, Global Investment Performance Standards, EMEA at CFA Institute discussed the benefits of the updated 2020 GIPS® standards for alternatives managers and capital allocators. In this blog, they focus on the potential pitfalls of not adopting the…

December 7, 2020

The 2020 GIPS®: Expanding Adoption for Managers & Allocators

Alternatives managers haven’t always been open to embracing the GIPS® standards, but that could be set to change with the 2020 update. For the first part of a two-part blog, we spoke to Iain McAra, Director, Global Investment Performance Standards, EMEA and Olivier Lebleu, CFA, Senior Director of Institutional Relations, EMEA from CFA Institute, to…

June 24, 2020

Allocator Secures Significant Investment from Morningstar, Inc.

We are proud to announce that Allocator has secured a significant amount of growth capital from the leading provider of independent investment research, Morningstar, Inc. (NASDAQ: MORN), in exchange for a minority stake in our company.